Baird Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,929
Closed -$357K 1814
2024
Q4
$357K Sell
23,929
-213
-0.9% -$3.47K ﹤0.01% 1494
2024
Q3
$462K Sell
24,142
-3,078
-11% -$63.8K ﹤0.01% 1402
2024
Q2
$563K Buy
27,220
+739
+3% +$14.7K ﹤0.01% 1346
2024
Q1
$498K Buy
26,481
+934
+4% +$16K ﹤0.01% 1382
2023
Q4
$368K Sell
25,547
-322,792
-93% -$4.39M ﹤0.01% 1457
2023
Q3
$6.05M Buy
348,339
+301,245
+640% +$6.28M 0.02% 571
2023
Q2
$980K Sell
47,094
-351,982
-88% -$7.65M ﹤0.01% 1117
2023
Q1
$9.39M Sell
399,076
-32,912
-8% -$884K 0.02% 446
2022
Q4
$12.1M Buy
431,988
+376,987
+685% +$9.64M 0.03% 393
2022
Q3
$1.29M Buy
55,001
+247
+0.5% +$7.46K ﹤0.01% 973
2022
Q2
$1.85M Sell
54,754
-225
-0.4% -$7.88K 0.01% 877
2022
Q1
$1.92M Sell
54,979
-34,363
-38% -$1.18M ﹤0.01% 926
2021
Q4
$2.72M Buy
89,342
+12,397
+16% +$404K 0.01% 811
2021
Q3
$2.52M Sell
76,945
-6,630
-8% -$212K 0.01% 851
2021
Q2
$2.53M Buy
+83,575
New +$2.75M 0.01% 818

Other funds holding OGN

Baird Financial Group's OGN Position: Q1 2025 in Review

Baird Financial Group sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 23,929 shares — an estimated $357K sold.

Baird Financial Group first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $12.1M in Q4 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Baird Financial Group reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Baird Financial Group sold 23,929 Organon & Co shares in Q1 2025, an estimated $357K.
  • Baird Financial Group first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
  • Baird Financial Group's Organon & Co position peaked at $12.1M in Q4 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Baird Financial Group's 13F filing for Q1 2025, filed 15 May 2025.